PPM1D amplification and WIP1 overexpression showed oncogenic properties across several cancer types and were associated with dismal outcome, mainly due to the suppression of p53 activity [14,15,16,17,18,19,20,21,22]. This evidence concerns the gene PPM1D and cancer.